Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | +3.60% | +5.65% | +596.46% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+596.46% | 204M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.23% | 21.6B | |
-12.38% | 22.31B | |
-6.36% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- JPMorgan Downgrades Elevation Oncology to Neutral from Overweight